文献速递骨质疏松与钙磷/甲状旁腺

增强子转录因子富集分析识别EZH2为骨质疏松易感基因

Transcription Factor Enrichment Analysis in Enhancers Identifies EZH2 as a Susceptibility Gene for Osteoporosis.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

研究将GWAS识别的骨质疏松相关SNP注释至增强子并进行转录因子富集分析,在汉族人群中进一步验证,发现EZH2和NRSF显著富集,EZH2的SNP rs111851041与髋部和脊柱骨密度相关,EZH2在成骨分化12至48小时表达下降,敲除小鼠功能验证显示EZH2与骨质疏松相关表型有关。

要点

  • 5081个骨质疏松相关SNP被定位到增强子,富集分析识别EZH2(Padj=0.028)和NRSF(Padj=0.038)为显著转录因子。
  • EZH2的SNP rs111851041与髋部骨密度(P=4.32×10-4)和脊柱骨密度(P=2.72×10-3)显著相关。
  • EZH2在成骨分化12至48小时表达显著下降,敲除小鼠功能验证显示其与骨质疏松相关表型有关。

核心结论

  • EZH2是结合骨质疏松相关增强子的常见转录因子,在中国人群中与骨密度相关,且功能上与骨表型相关。

研究设计与样本

  • 研究首先对GWAS识别的所有骨质疏松相关SNP进行增强子注释和转录因子富集分析,随后在汉族人群中进行遗传关联分析,并进行成骨分化表达分析和敲除小鼠功能验证。

主要发现

  • 共5081个骨质疏松相关SNP被定位到增强子。
  • 转录因子富集分析经多重检验校正后识别出2个显著转录因子:EZH2(Padj=0.028)和NRSF(Padj=0.038)。
  • EZH2中的SNP rs111851041经多重检验校正后与髋部骨密度(P=4.32×10-4)和脊柱骨密度(P=2.72×10-3)显著相关。
  • EZH2表达在成骨分化12至48小时显著下降。
  • 功能验证显示EZH2在敲除小鼠中与骨质疏松相关表型相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Genome-wide association studies (GWASs) have identified hundreds of single nucleotide polymorphisms (SNPs) associated with osteoporosis. Most of these SNPs are noncoding variants and could be mapped to enhancers. Transcription factors (TFs) play important roles in gene regulation via enhancers harboring these SNPs; thus, we aimed to identify common regulatory TFs binding to enhancers associated with osteoporosis. METHODS: We first annotated all the osteoporosis-related SNPs identified by GWASs to enhancers and conducted TF enrichment analyses to identify common TFs binding to osteoporosis-associated enhancers. We further conducted genetic association analyses between the identified TFs and bone mineral density (BMD) in a Han Chinese population. RESULTS: After functional annotation, a total of 5081 osteoporosis-related SNPs were mapped to enhancers. TF enrichment analyses identified 2 significant TFs after multiple testing adjustments, which are EZH2 (Padj = .028) and NRSF (Padj = .038). We also found 1 SNP, rs111851041, in EZH2 was significantly associated with BMD both at the hip and spine after multiple testing adjustments (hip BMD: P = 4.32 × 10-4; spine BMD: P = 2.72 × 10-3). The expression of EZH2 decreased significantly from 12 to 48 hours of osteogenic differentiation. And functional validation showed that EZH2 was associated with osteoporosis-related phenotypes in knockout mice. CONCLUSIONS: By conducting TF enrichment analyses, we identified EZH2 as a common TF binding to osteoporosis-associated enhancers, and EZH2 was also associated with BMD in a Chinese population. EZH2 is functionally related to bone phenotypes. The identified gene could provide new insight into osteoporosis pathophysiology and highlight opportunities for future clinical and pharmacological research on osteoporosis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li M, Yao S, Duan YY, et al. Transcription Factor Enrichment Analysis in Enhancers Identifies EZH2 as a Susceptibility Gene for Osteoporosis. J Clin Endocrinol Metab. 2020. PMID: 31833556. doi:10.1210/clinem/dgz270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。